Do Wall Street Analysts Like Baxter International Stock? As Baxter International has underperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's prospects. Barchart · Aug 7, 2024
Baxter International to lay off ‘less than 5%’ of its global workforce Baxter International, a maker of renal and hospital products, plans to lay off workers as part of a cost reduction plan aimed at addressing what’s been a challenging time for the company. Chicago Tribune · Feb 9, 2023
Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook Baxter International Inc (NYSE:BAX) has posted Q1 revenue of $3.71 billion, beating the consensus of $3.68 billion, up 26% on a reported basis, 29% on a constant currency basis, and 3% on an operational basis. Adjusted EPS of $0.93 increased 22%, ahead of the consensus of $0.80. Baxter's newly acquired Hillrom businesses… Benzinga · Apr 28, 2022